KDM6B and breast carcinoma: To determine whether miR-138-5p mediated the inhibitory effect of MDA-MB-231 cells on KDM6B expression in macrophages, we first measured miR-138-5p levels in phenotypically distinct breast cancer cell lines, as well as in the nontumorigenic cell line MCF10A.